Transdermal Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Transdermal Therapeutics's estimated annual revenue is currently $13.9M per year.(i)
  • Transdermal Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Transdermal Therapeutics has 69 Employees.(i)
  • Transdermal Therapeutics grew their employee count by 1% last year.

Transdermal Therapeutics's People

NameTitleEmail/Phone
1
PresidentReveal Email/Phone
2
Staff PharmacistReveal Email/Phone
3
Sr. Medical Science LiaisonReveal Email/Phone
4
Pain Management Medical Science LiaisonReveal Email/Phone
5
Pharmacy TechnicianReveal Email/Phone
6
Pharmacist-in-ChargeReveal Email/Phone
7
Medical Liaison Bioscience Rep. with Transdermal TherapeuticsReveal Email/Phone
8
Medical Science LiaisonReveal Email/Phone
9
Senior Specialty Sales RepresentativeReveal Email/Phone
10
Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.9M944%N/AN/A
#2
$10.3M51-28%N/AN/A
#3
$44.8M2237%N/AN/A
#4
$16.5M82-1%N/AN/A
#5
$26.7M1334%N/AN/A
#6
$42M209-3%N/AN/A
#7
$1.4M148%N/AN/A
#8
$66.3M330-3%N/AN/A
#9
$13.9M691%N/AN/A
#10
$32.2M160-10%N/AN/A
Add Company

What Is Transdermal Therapeutics?

Transdermal Therapeutics is a compound pharmacy committed to providing prescribers the highest quality customized pain management medications for their patients. It is our vision to continue providing effective non addictive pain solutions for patients and prescribers. In addition, we are partnering with the medical community through focused research and discovery of additional solutions for patients who suffer with debilitating pain, while maintaining a safe, cost effective treatment option.

keywords:N/A

N/A

Total Funding

69

Number of Employees

$13.9M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.3M691%N/A
#2
$6.1M69-13%$16.5M
#3
$15.5M69-20%N/A
#4
$11.3M708%N/A
#5
$12.9M700%N/A